Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
about
Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer TherapyHigh-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsCD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationFactors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.Immune restoration following hematopoietic stem cell transplantation: an evolving target.The graft-versus-lymphoma effect: clinical review and future opportunities.CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in miceSafety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignanciesCytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
P2860
Q26749560-C9EFB53F-CC5F-4E75-9D09-F43B01D93B1CQ33806895-5EF0E35F-B74B-45A4-9B27-FB52583CE75BQ33968168-EE9A374B-C640-424B-9AB8-FCF6B8521FD2Q35142329-DC916866-BF84-4EF8-9977-21DE41B6FAC0Q35588845-20186C95-E922-4BC2-A19B-09594837BDB8Q35828638-2F2640C1-C337-4EC1-BCF1-5D7CD254F196Q36075296-C350D569-6D48-42CF-8BB1-A2EA00BF8E51Q36128232-B5203387-9130-4C2E-91D5-E3614D0819AFQ37079114-8F5EFD88-6C5F-4492-851F-07D6FB747AD6Q37409777-9A459499-CD52-4891-9B47-7CAECC5D6BFAQ39966752-2830455A-2A46-4B6B-A079-21C96E6ED974
P2860
Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@ast
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@en
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@nl
type
label
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@ast
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@en
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@nl
prefLabel
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@ast
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@en
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@nl
P2860
P1433
P1476
Donor lymphocyte infusions to ...... ood or marrow transplantation.
@en
P2093
Ephraim J Fuchs
Leo Luznik
P2860
P304
P356
10.1177/107327480200900205
P577
2002-03-01T00:00:00Z